Glaukos Corporation (GKOS) — Stock Score Summary

Glaukos Corporation (GKOS) has a MoatMap StockRank of 67/100 based on Quality (48/100), Value (32/100), and Momentum (71/100) factor scores. The current signal is BUY. Glaukos is an innovative ophthalmic medical technology company. While it has strong growth potential in glaucoma treatment, it lacks direct alignment with our 18-month macro themes and does not meet our strict valuation and profitability criteria.

Glaukos Corporation is an ophthalmic medical technology company dedicated to the development and commercialization of innovative surgical devices and pharmaceutical therapies for the treatment of glaucoma. The company is a pioneer and market leader in Minimally Invasive Glaucoma Surgery (MIGS), leveraging its proprietary iStent technology to establish a new treatment paradigm. Glaukos's competitive strength derives from its first-mover advantage, strong intellectual property, and focus on addressing unmet needs in ophthalmology.

Key Financial Metrics

Price$126.34
Market Cap$6.3B
P/E (Forward)253.96
Price/Book10.58
Return on Equity-26.4%
Return on Invested Capital-23.8%
Debt/Equity15.78
Gross Margin78.1%
Operating Margin-13.2%
Revenue Growth41.2%
Free Cash Flow$6M

Glaukos Corporation operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Glaukos Corporation’s (GKOS) StockRank?
MoatMap’s StockRank for Glaukos Corporation (GKOS) is 67/100, with a Buy signal. It is a composite of Quality (48), Value (32), and Momentum (71) factor ranks across MoatMap’s 19,000+ stock universe.
Does Glaukos Corporation have an economic moat?
Glaukos Corporation (GKOS) has a Quality factor score of 48/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Glaukos Corporation a buy, hold, or sell?
MoatMap’s current signal for Glaukos Corporation (GKOS) is Buy, based on a StockRank of 67/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Glaukos Corporation in?
Glaukos Corporation (GKOS) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksGKOS deep dive reportAI ChampionsHow we score stocksSense-check another stock